Beautiful phase 2 data on a combined uricase and tolerigenic nanoparticle to reduce reactions and maintain irate lowering efficacy over 28 days. Roll on the HTH phase 3 with pegloticase #ACR19 @RheumNow #gout Abs 1235 https://t.co/NnMMgnbPbH